Source-grounded facts extracted from Airsculpt Technologies, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Airsculpt Technologies, Inc. updated its the three months ended March 31, 2026 guidance (reaffirmed).
“On May 8, 2026 , AirSculpt Technologies, Inc. (the “Company”) issued a press release announcing results for the three months ended March 31, 2026.”
Earnings Releases
Airsculpt Technologies, Inc. reported full year 2026 results: revenue $151 to $157 million. Guidance initiated.
“The Company projects full year 2026 revenue and adjusted EBITDA guidance as follows: • Revenue of approximately $151 to $157 million • Adjusted EBITDA of approximately $15 to $17 million”
Earnings Releases
Airsculpt Technologies, Inc. reported fourth quarter and twelve months ended December 31, 2025 results: revenue $33.4 million, net income $1.3 million. Guidance reaffirmed.
“• Case volume was 2,604 for the fourth quarter of 2025, representing a 15.0% decline from the fiscal year 2024 fourth quarter case volume of 3,064; • Revenue declined 14.6% to $33.4 million from $39.2 million in the fiscal year 2024 fourth quarter; • Net loss for the quarter was $1.3 million compared to net loss of $5.0 million in the fiscal year 2024 fourth”
Earnings Releases
Airsculpt Technologies, Inc. reported first quarter 2026 results: revenue first quarter 2026 revenue of $38.5 to $39.5 million. Guidance initiated.
“The Company expects first quarter 2026 revenue of $38.5 to $39.5 million representing same-store revenue of approximately flat at the midpoint.”
Philip Bodie was appointed as Chief Accounting Officer at Airsculpt Technologies, Inc..
“Effective November 6, 2024, the board of directors of the Company appointed Philip Bodie to serve as Chief Accounting Officer”
Dennis Dean was appointed as Interim Chief Executive Officer at Airsculpt Technologies, Inc..
“On August 8, 2024, the Board appointed Dennis Dean, the Company’s Chief Financial Officer, as the Interim Chief Executive Officer of the Company, effective as of August 8, 2024.”
Todd Magazine resigned as member of the board of directors at Airsculpt Technologies, Inc..
“In connection with stepping down from his role as Chief Executive Officer of the Company, Mr. Magazine resigned from his position as a member of the board of directors of the Company (the “Board”), effective as of August 8, 2024.”
Todd Magazine departed as Chief Executive Officer at Airsculpt Technologies, Inc..
“On August 8, 2024, Todd Magazine stepped down from his role as Chief Executive Officer of AirSculpt Technologies, Inc. (the “Company”), effective as of August 8, 2024.”
Earnings Releases
Airsculpt Technologies, Inc. reported first quarter ended March 31, 2024 results: revenue $47.6 million, net income $6.0 million, EPS $0.10. Guidance reaffirmed.
“results for the first quarter ended March 31, 2024. First Quarter • Cases increased 2.9% over the prior year period to 3,746 • Revenue increased 3.9% over the prior year to $47.6 million • Net income of $6.0 million for the quarter compared to $(0.0) million in the prior year period • Diluted income per share for the quarter of $0.10 • Six planned openings in”
Shareholder Votes
Airsculpt Technologies, Inc. shareholders approved Ratification of appointment of Grant Thornton as independent registered public accounting firm for fiscal year ending December 31, 2024 at the 2024-05-07 meeting.
“2. The ratification of the appointment of Grant Thornton as our independent registered public accounting firm for the fiscal year ending December 31, 2024: Votes For Votes Against Abstain Broker Non-Votes 56,493,431 2,620 9,165 0 The proposal was approved.”
Shareholder Votes
Airsculpt Technologies, Inc. shareholders approved Election of Class III director nominees at the 2024-05-07 meeting.
“The following shares were present at the Annual Meeting, either in person at the virtual shareholder meeting or by proxy. The results of the proposals are as follows: 1. The election of the two Class III director nominees to serve for a term of three years: Name Votes For Votes Against Abstain Broker Non-Votes Dr. Aaron Rollins 46,095,453 533,100 310 9,876,353 Caroline Chu 45,666,129 962,658 76 9,876,353 Both Class III director nominees were duly elected.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.